Evidence map›Paper›PMID 20512123›Full record

ArticleNature biotechnology2010

Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511.

Sergey Rodin, Anna Domogatskaya, Susanne Ström, Emil M Hansson, Kenneth R Chien, José Inzunza, Outi Hovatta, Karl Tryggvason

Abstract read
PubMed Publisher
In one paragraph

Article in Nature biotechnology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 251 papers.

0numbers the graph read from it
0cells of the map it votes in
251citing papers in PubMed
22.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

251 citing papers in PubMed, 556 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Vascular basement membrane laminins modulate functional zonation of cerebral microvessels.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Advancements in theFrontiers in toxicology · 2025
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

191 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Sergey RodinDivision of Matrix Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.
Anna Domogatskaya
Susanne Ström
Emil M Hansson
Kenneth R Chien
José Inzunza
Outi Hovatta
Karl Tryggvason
Karolinska Institutet · SEKarolinska University Hospital · SEInstitute for Stem Cell Biology and Regenerative Medicine · INMassachusetts General Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe a system for culturing human embryonic stem (hES) cells and induced pluripotent stem (iPS) cells on a recombinant form of human laminin-511, a component of the natural hES cell niche. The system is devoid of animal products and feeder cells and contains only one undefined component, human albumin. The hES cells self-renewed with normal karyotype for at least 4 months (20 passages), after which the cells could produce teratomas containing cell lineages of all three germ layers. When plated on laminin-511 in small clumps, hES cells spread out in a monolayer, maintaining cellular homogeneity with approximately 97% OCT4-positive cells. Adhesion of hES cells was dependent on alpha6beta1 integrin. The use of homogeneous monolayer hES or iPS cell cultures provides more controllable conditions for the design of differentiation methods. This xeno-free and feeder-free system may be useful for the development of cell lineages for therapeutic purposes.

Indexed as

Cell AdhesionCell Culture TechniquesCell LineCell MembraneCell ProliferationFlow CytometryHumansInduced Pluripotent Stem CellsIntegrinsLamininPluripotent Stem CellsReceptors, Cell SurfaceRecombinant ProteinsTime FactorsIntegrinsLamininlaminin-511, humanReceptors, Cell SurfaceRecombinant Proteins

Identifiers

PMID20512123
OpenAlexW2076439120

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.